Epstein Secrets

ce exam." The White House "is pushing tonight, back calling it a book of falsehoods." On ABC World News TonightVi (7/7, story 4, 2:35, Muir, 7.1M), Jonathan Karl said a "statement from a White House spokesperson accuses Mary Trump of writing the book for financial gain. Regarding the specifics of what she wro

shown to be effective in clinical trials." CNN (7/7, Cohen, Bonifield, 83.16M) reports on its website that Novavax CEO/President Stanley Erck "said Novavax's vaccine could be on the market by the first quarter of next year." The Hill (7/7, Budryk, 2.98M) reports that "the award will also cover a large-

rnment To Pay $1.6B For Rush Vaccine Development. The CBS Evening NewsVi (7/7, story 3, 1:40, O'Donnell, 4.24M) reported, "Maryland biotech company Novavax is in the hunt for a coronavirus vaccine, and getting a major dose of funding from the government's Operation Warp Speed program." The New York lime

BC World News Tonight <https://playvideo.bulletinintelligence.corn/826e4ac563c94366b10696c78d58aeff?pubid=fbi> (11/23, story 4, 1:10, Muir, 7.67M), Jonathan Karl called Murphy's announcement as "the first step towards a Biden Administration," as well as "the first acknowledgment...from anywhere in the Trump A

ted by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behi

of a presidential transition to...Biden was 'solely mine' despite" Trump's tweet. On ABC World News TonightVi (11/23, story 4, 1:10, Muir, 7.67M), Jonathan Karl called Murphy's announcement as "the first step towards a Biden Administration," as well as "the first acknowledgment...from anywhere in the Trump

ed by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behin